These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 10664826

  • 21. Blockade of the mineralocorticoid receptor in healthy men: effects on experimentally induced panic symptoms, stress hormones, and cognition.
    Otte C, Moritz S, Yassouridis A, Koop M, Madrischewski AM, Wiedemann K, Kellner M.
    Neuropsychopharmacology; 2007 Jan; 32(1):232-8. PubMed ID: 17035932
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder.
    Kanter ED, Wilkinson CW, Radant AD, Petrie EC, Dobie DJ, McFall ME, Peskind ER, Raskind MA.
    Biol Psychiatry; 2001 Aug 15; 50(4):238-45. PubMed ID: 11522257
    [Abstract] [Full Text] [Related]

  • 24. Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
    Zwanzger P, Baghai TC, Schuele C, Ströhle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R.
    Neuropsychopharmacology; 2001 Nov 15; 25(5):699-703. PubMed ID: 11682253
    [Abstract] [Full Text] [Related]

  • 25. Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects.
    Flint AJ, Koszycki D, Bradwejn J, Vaccarino FJ.
    Psychoneuroendocrinology; 2000 Aug 15; 25(6):633-47. PubMed ID: 10840174
    [Abstract] [Full Text] [Related]

  • 26. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder.
    Rasmusson AM, Lipschitz DS, Wang S, Hu S, Vojvoda D, Bremner JD, Southwick SM, Charney DS.
    Biol Psychiatry; 2001 Dec 15; 50(12):965-77. PubMed ID: 11750893
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder.
    Geracioti TD, Baker DG, Kasckow JW, Strawn JR, Jeffrey Mulchahey J, Dashevsky BA, Horn PS, Ekhator NN.
    Psychoneuroendocrinology; 2008 May 15; 33(4):416-24. PubMed ID: 18295412
    [Abstract] [Full Text] [Related]

  • 30. Behavioral and neuroendocrine responses to sodium lactate infusion in subjects with posttraumatic stress disorder.
    Jensen CF, Keller TW, Peskind ER, McFall ME, Veith RC, Martin D, Wilkinson CW, Raskind MA.
    Am J Psychiatry; 1997 Feb 15; 154(2):266-8. PubMed ID: 9016280
    [Abstract] [Full Text] [Related]

  • 31. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA, Koszycki D, Bradwejn J.
    Depress Anxiety; 2004 Feb 15; 20(2):51-8. PubMed ID: 15390214
    [Abstract] [Full Text] [Related]

  • 32. Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients.
    Wichmann S, Kirschbaum C, Böhme C, Petrowski K.
    Psychoneuroendocrinology; 2017 Sep 15; 83():135-141. PubMed ID: 28623762
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of 35% carbon dioxide (CO2) inhalation in patients with post-traumatic stress disorder (PTSD): A double-blind, randomized, placebo-controlled, cross-over trial.
    Kellner M, Muhtz C, Nowack S, Leichsenring I, Wiedemann K, Yassouridis A.
    J Psychiatr Res; 2018 Jan 15; 96():260-264. PubMed ID: 29128558
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder.
    van Megen HJ, Westenberg HG, Den Boer JA, Kahn RS.
    Eur Neuropsychopharmacol; 1996 Aug 15; 6(3):187-94. PubMed ID: 8880078
    [Abstract] [Full Text] [Related]

  • 37. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J.
    Depress Anxiety; 2005 Aug 15; 21(3):143-8. PubMed ID: 16001448
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.
    de Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EG, Westenberg HG.
    Psychoneuroendocrinology; 2007 Apr 15; 32(3):215-26. PubMed ID: 17296270
    [Abstract] [Full Text] [Related]

  • 40. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D, di Michele F, Zwanzger P, Pasini A, Baghai TC, Schüle C, Rupprecht R, Romeo E.
    Neuropsychopharmacology; 2005 Jan 15; 30(1):192-5. PubMed ID: 15467707
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.